Literature DB >> 23830891

Activin receptor-like kinase 7 mediates high glucose-induced H9c2 cardiomyoblast apoptosis through activation of Smad2/3.

Lin Liu1, Wen-yuan Ding, Jing Zhao, Zhi-hao Wang, Ming Zhong, Wei Zhang, Yu-guo Chen, Yun Zhang, Li Li, Meng-xiong Tang.   

Abstract

Cardiomyocyte apoptosis is an important pathological change of diabetic cardiomyopathy. How the elevated glucose levels cause cell apoptosis remains unknown. The aim of our study was to investigate whether activin receptor-like kinase 7 (ALK7)-Smad2/3 signaling pathway plays an important role in high glucose-induced cardiomyocyte apoptosis. H9c2 cardiomyoblasts and neonatal rat cardiomyocytes were treated with 33mmol/l glucose. The expression of ALK7, Smad2 and Smad3 were inhibited by small interfering RNA respectively. The level of ALK7, total Smad2/3, phosphorylated Smad2/3, B-cell lymphoma-2 (Bcl-2) and cleaved Caspase3 were evaluated using western blot. The apoptosis rate was detected by flow cytometer. High glucose treatment caused the apoptosis of H9c2 cardiomyocyte and the inhibition of Smad2 or Smad3 attenuated this apoptosis. ALK7 existed in both H9c2 cardiomyoblasts and neonatal rat cardiomyocytes and high ambient glucose upregulated its expression. The increased expression level of cleaved Caspase3 and apoptosis rate and decreased expression of Bcl-2 were reversed after ALK7 was inhibited. The expression of phosphorylated Smad2/3 also decreased after the knockdown of ALK7. Our findings suggest that ALK7 mediates high ambient glucose-induced H9c2 cardiomyoblasts apoptosis through the activation of Smad2/3.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ALK; ActRII; Activin receptor-like kinase 7; Apoptosis; B-cell lymphoma-2; BMPs; Bcl-2; Cardiomyocyte; DCM; DMEM; Dulbecco's modified Eagle's medium; FBS; GDF; Glucose; Smad2/3; TGF-β; X-linked inhibitor of apoptosis protein; XIAP; activin receptor-like kinase; activin type II receptors; bone morphogenetic proteins; diabetic cardiomyopathy; fetal bovine serum; growth and differentiation factors; siRNA; small interfering RNA; transforming growth factor-β

Mesh:

Substances:

Year:  2013        PMID: 23830891     DOI: 10.1016/j.biocel.2013.06.018

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  13 in total

1.  NLRP3 inflammasome and glia maturation factor coordinately regulate neuroinflammation and neuronal loss in MPTP mouse model of Parkinson's disease.

Authors:  Hayate Javed; Ramasamy Thangavel; Govindhasamy Pushpavathi Selvakumar; Iuliia Dubova; Noah Schwartz; Mohammad Ejaz Ahmed; Smita Zaheer; Duraisamy Kempuraj; Shankar Iyer; Asgar Zaheer; Mohammad Moshahid Khan
Journal:  Int Immunopharmacol       Date:  2020-04-04       Impact factor: 4.932

2.  Activin receptor-like kinase 7 silencing alleviates cardiomyocyte apoptosis, cardiac fibrosis, and dysfunction in diabetic rats.

Authors:  Lin Liu; Xin Zhou; Qiyu Zhang; Li Li; Yuanyuan Shang; Zhihao Wang; Ming Zhong; Yuguo Chen; Wei Zhang; Mengxiong Tang
Journal:  Exp Biol Med (Maywood)       Date:  2022-06-06

3.  A ROCK1 Inhibitior Fasudil Alleviates Cardiomyocyte Apoptosis in Diabetic Cardiomyopathy by Inhibiting Mitochondrial Fission in a Type 2 Diabetes Mouse Model.

Authors:  Xinhui Fan; Xiaoxing Li; Huiruo Liu; Feng Xu; Xiaoping Ji; Yuguo Chen; Chuanbao Li
Journal:  Front Pharmacol       Date:  2022-07-05       Impact factor: 5.988

4.  NLRP3 gene silencing ameliorates diabetic cardiomyopathy in a type 2 diabetes rat model.

Authors:  Beibei Luo; Bo Li; Wenke Wang; Xiangjuan Liu; Yanfei Xia; Cheng Zhang; Mingxiang Zhang; Yun Zhang; Fengshuang An
Journal:  PLoS One       Date:  2014-08-19       Impact factor: 3.240

5.  Prohibitin overexpression improves myocardial function in diabetic cardiomyopathy.

Authors:  Wen-qian Dong; Min Chao; Qing-hua Lu; Wei-li Chai; Wei Zhang; Xue-ying Chen; Er-shun Liang; Ling-bo Wang; Hong-liang Tian; Yu-guo Chen; Ming-xiang Zhang
Journal:  Oncotarget       Date:  2016-01-05

Review 6.  NLRP3 Inflammasome as a Molecular Marker in Diabetic Cardiomyopathy.

Authors:  Beibei Luo; Feng Huang; Yanli Liu; Yiying Liang; Zhe Wei; Honghong Ke; Zhiyu Zeng; Weiqiang Huang; Yan He
Journal:  Front Physiol       Date:  2017-07-25       Impact factor: 4.566

7.  A Novel Circular RNA Mediates Pyroptosis of Diabetic Cardiomyopathy by Functioning as a Competing Endogenous RNA.

Authors:  Fan Yang; Anqi Li; Ying Qin; Hui Che; Yueqiu Wang; Jie Lv; Yang Li; Hui Li; Er Yue; Xueying Ding; Yahan Yu; Yunlong Bai; Lihong Wang
Journal:  Mol Ther Nucleic Acids       Date:  2019-07-17       Impact factor: 8.886

8.  HMGB1 mediates hyperglycaemia-induced cardiomyocyte apoptosis via ERK/Ets-1 signalling pathway.

Authors:  Wen-Ke Wang; Qing-Hua Lu; Jia-Ning Zhang; Ben Wang; Xiang-Juan Liu; Feng-Shuang An; Wei-Dong Qin; Xue-Ying Chen; Wen-Qian Dong; Cheng Zhang; Yun Zhang; Ming-Xiang Zhang
Journal:  J Cell Mol Med       Date:  2014-09-11       Impact factor: 5.310

9.  BRD7 mediates hyperglycaemia-induced myocardial apoptosis via endoplasmic reticulum stress signalling pathway.

Authors:  Xiao-Meng Wang; Ying-Cui Wang; Xiang-Juan Liu; Qi Wang; Chun-Mei Zhang; Li-Ping Zhang; Hui Liu; Xin-Yu Zhang; Yang Mao; Zhi-Ming Ge
Journal:  J Cell Mol Med       Date:  2016-12-13       Impact factor: 5.310

Review 10.  NLRP3 Inflammasome Biomarker-Could Be the New Tool for Improved Cardiometabolic Syndrome Outcome.

Authors:  Andra-Iulia Suceveanu; Laura Mazilu; Niki Katsiki; Irinel Parepa; Felix Voinea; Anca Pantea-Stoian; Manfredi Rizzo; Florin Botea; Vlad Herlea; Dragos Serban; Adrian-Paul Suceveanu
Journal:  Metabolites       Date:  2020-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.